Mar 29, 2018
Dr. Robert Pearl is the former CEO
of the Permanente Medical Group (1999-2017), the nation’s largest
medical group, and former president of the Mid-Atlantic Permanente
Medical Group (2009-2017). In these roles, he led 9,000 physicians,
35,000 staff, and was responsible for the nationally recognized
medical care of 4...
Mar 22, 2018
Prior to Aventria, David held
several commercial leadership roles, including Head of
Oncology Marketing at Genentech and VP Strategic Marketing at
Schering AG, specializing in commercializing oncology and specialty
products. He was also instrumental in the commercialization of
Taxotere, Fludara, Herceptin, and Rituxan.
Mar 15, 2018
Julie is an executive
pharmaceutical leader with over 20 years of experience across all
phases of development both on the commercial and research sides of
the organization. She leverages her Masters in Business
Administration and Doctorate of Pharmacy to develop and deliver
strategic patient-centric value propositions...
Mar 8, 2018
Wayne Crandall is the president and CEO of NoteSwift. Crandall's career in technology spans sales, marketing, product management, strategic development, and operations. Prior to joining the NoteSwift team, Crandall was president and CEO of CYA Technologies, and then took over as president of enChoice, which specialized...
Mar 1, 2018
Moore, is CEO of the health care IT
analyst firm, Chilmark Research, which he founded in 2007. Chilmark
Research was founded on the simple premise of conducting the best
research possible that will ultimately lead to improvements in the
quality of care a patient receives. Having spent many years in
other industry...